Long non‐coding RNA TMEM147 antisense RNA 1/microRNA‐124/signal transducer and activator of transcription 3 axis in estrogen receptor‐positive breast cancer

Abstract

AbstractObjectiveThis research aimed to probe the expression of long noncoding RNA TMEM147 antisense RNA 1 (TMEM147‐AS1)/micro‐RNA (miR)‐124/signal transducer and activator of transcription 3 (STAT3) axis in estrogen receptor (ER)‐positive breast cancer (BC).MethodsSixty ER‐positive BC patients undergoing surgical treatment were gathered. TMEM147‐AS1, miR‐124, and STAT3 expression levels in BC cells and tissues were measured. The binding sites of TMEM147‐AS1 and miR‐124, miR‐124, and STAT3 were analyzed and validated. The miR‐124, STAT3 overexpression (oe) sequences, TMEM147‐AS1 oe, and interference sequences and their control sequences were planned and cells were transfected to assess their functions in BC cells biological functions.ResultsTMEM147‐AS1, as well as STAT3 was extremely expressed and miR‐124 was lowly expressed in BC cells and tissues. Interference with TMEM147‐AS1 restrained ER‐positive BC cell malignant activities. Mechanistically, TMEM147‐AS1 could competitively bind miR‐124 in refraining miR‐124 expression, and STAT3 was a target gene of miR‐124. Oe of miR‐124 effectively reversed the enhancement of BC cell proliferation and invasion induced by TMEM147‐AS1 upregulation. Oe of STAT3 could reverse the inhibitory effect of miR‐124 on BC cell malignant behaviors.ConclusionTMEM147‐AS1 has oncogenic activity in ER‐positive BC, which may be a result of the altered miR‐124/STAT3 axis. Therefore, targeting the TMEM147‐AS1/miR‐124/STAT3 axis may be a target for ER‐positive BC therapy.